Dr Ka-Wai Wan

Dr. Ka-Wai Wan
Principal Lecturer in Pharmaceutics
School of Pharmacy and Biomedical Sciences
University of Central Lancashire
UK
 

Dr Ka-Wai Wan is a pharmacist by training and graduated from The School of Pharmacy (University of London). She was trained as a hospital pharmacist before completing her PhD in targeted polymeric drug delivery systems at the Welsh School of Pharmacy (Cardiff). Ka-Wai is currently working as a Principal Lecturer in Pharmaceutics and a Course Leader for the MSc Industrial Pharmaceutics course at the School of Pharmacy and Biomedical Sciences at the University of Central Lancashire (UCLan, Preston). Her research interests lie in the field of advanced drug delivery systems (polymers, liposomes and colloidal systems) for targeted therapy and delivery of macromolecules such as nucleotides and proteins. She is particularly interested in the applications and biological fate (intracellular trafficking and toxicological effects) of these nanostructured delivery systems for the treatment of diseases. Current research projects involve targeting to the tumor endothelium using integrin-targeted nanoparticles as a means of anti-angiogenic or vascular targeting for the treatment of cancer and the use of nanoparticulate drug delivery systems for enhanced localization and delivery of anti-infectives through the skin.

Dr Ka-Wai Wan principal research interests lie in the field of advanced drug delivery systems (polymers,liposomes and colloidal systems) for targeted therapy and macromolecules delivery. She is particularly interested in polymer therapeutics as polymers have the advantages of being versatile and multifunctional. Past research experience has focused on nanomedicine with the use of polymeric materials as vascular targeting agents via the v3 integrin system, for the drug delivery of conventional drugs and macromolecules such as DNA and proteins. Studies on their uptake mechanism and intracellular fate were also carried out. Current research projects also involve the use of nanoparticulate systems for enhanced localization and delivery of anti-infectives through the skin as well as the development of polymer and lipid-based nanoparticulate drug delivery systems for the treatment of solid tumors